Mixed Topics
Conference Coverage
CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases?
New research suggests that CAR T-cell therapy might prove to be a game-changing treatment for lupus and two other autoimmune diseases.
Latest News
FDA mandates five changes to iPLEDGE program for isotretinoin
The changes follow a March 2023 meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs...
News
‘Hidden hearing loss’ may cause tinnitus: Study
“In other words, the brain tries to compensate for the loss of hearing by increasing its activity, resulting in the perception of a phantom sound...
News
FDA approves pirtobrutinib for previously treated CLL/SLL
FDA greenlights pirtobrutinib as third-line treatment for chronic lymphocytic leukemia or small lymphocytic lymphoma in adults.
Original Research
Increasing Local Productivity Through a Regional Antimicrobial Stewardship Collaborative
This study examined whether an antimicrobial stewardship collaborative that spanned 5 Veterans Affairs facilities could improve data reporting,...
Commentary
Equity and Inclusion in Military Recruitment: The Case for Neurodiversity in Uniform
History has shown that discrimination in military recruitment only weakens the fighting force, whereas diversity, including neurodiversity, in the...
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
Latest News
New consensus guide on rare drug hypersensitivity reaction
To support clinicians in diagnosing and managing DRESS, a steering committee conducted a literature review to examine current research, identify...
News
FDA OKs new agent to block chemotherapy-induced neutropenia
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
Latest News
Redispensing unused cancer meds cuts waste, saves money
Researchers compared the reduction in drug waste and cost savings from redispensing oral anticancer drugs versus the standard practice of...